Biosyent Inc (BIOYF)
7.49
-0.13
(-1.71%)
USD |
OTCM |
Jun 28, 16:00
Biosyent Price to Book Value: 3.393 for June 28, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 28, 2024 | 3.393 |
| June 27, 2024 | 3.452 |
| June 26, 2024 | 3.452 |
| June 25, 2024 | 3.399 |
| June 24, 2024 | 3.452 |
| June 21, 2024 | 3.33 |
| June 20, 2024 | 3.258 |
| June 18, 2024 | 3.194 |
| June 17, 2024 | 3.140 |
| June 14, 2024 | 3.171 |
| June 13, 2024 | 3.081 |
| June 12, 2024 | 3.103 |
| June 11, 2024 | 3.031 |
| June 10, 2024 | 3.031 |
| June 07, 2024 | 3.031 |
| June 06, 2024 | 3.026 |
| June 05, 2024 | 3.020 |
| June 04, 2024 | 3.020 |
| June 03, 2024 | 3.020 |
| May 31, 2024 | 3.017 |
| May 30, 2024 | 3.007 |
| May 29, 2024 | 2.999 |
| May 28, 2024 | 3.153 |
| May 24, 2024 | 2.986 |
| May 23, 2024 | 2.968 |
| Date | Value |
|---|---|
| May 22, 2024 | 2.968 |
| May 21, 2024 | 2.999 |
| May 20, 2024 | 3.171 |
| May 17, 2024 | 3.026 |
| May 16, 2024 | 2.836 |
| May 15, 2024 | 2.833 |
| May 14, 2024 | 2.788 |
| May 13, 2024 | 2.870 |
| May 10, 2024 | 2.870 |
| May 09, 2024 | 2.870 |
| May 08, 2024 | 2.873 |
| May 07, 2024 | 2.873 |
| May 06, 2024 | 2.873 |
| May 03, 2024 | 2.891 |
| May 02, 2024 | 2.872 |
| May 01, 2024 | 2.872 |
| April 30, 2024 | 2.868 |
| April 29, 2024 | 2.873 |
| April 26, 2024 | 2.850 |
| April 25, 2024 | 2.850 |
| April 24, 2024 | 2.850 |
| April 23, 2024 | 2.850 |
| April 22, 2024 | 2.851 |
| April 19, 2024 | 2.840 |
| April 18, 2024 | 2.840 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.460
Minimum
Mar 18 2020
4.457
Maximum
Jun 24 2021
3.081
Average
3.031
Median
Jun 07 2024
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.4445 |
| Aurinia Pharmaceuticals Inc | 2.153 |
| Edesa Biotech Inc | 3.183 |
| Lexaria Bioscience Corp | 5.506 |
| Xenon Pharmaceuticals Inc | 3.322 |
Price to Book Value Related Metrics
| PE Ratio | 17.23 |
| PS Ratio | 3.709 |
| PEG Ratio | 0.4082 |
| Price to Free Cash Flow | 17.37 |
| Price | 7.49 |
| Earnings Yield | 5.80% |
| Market Cap | 86.77M |
| PEGY Ratio | 0.3927 |
| Operating PE Ratio | 14.89 |
| Normalized PE Ratio | 17.21 |